Weber Gallagher Kathleen's Insider Trades & SAST Disclosures
Weber Gallagher Kathleen's most recent trade in Orasure Technologies Inc. was a trade of 88,148 Common Stock done . Disclosure was reported to the exchange on March 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Weber Gallagher Kathleen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 88,148 | 399,518 (0%) | 0% | 0 | Common Stock | |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.63 per share. | 01 Mar 2025 | 8,312 | 391,206 (0%) | 0% | 3.6 | 30,152 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 35,083 | 325,116 (0%) | 0% | 0 | Common Stock | |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.95 per share. | 01 Feb 2025 | 9,945 | 315,171 (0%) | 0% | 4.0 | 39,308 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.95 per share. | 01 Feb 2025 | 3,801 | 311,370 (0%) | 0% | 4.0 | 15,023 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.78 per share. | 05 Jan 2025 | 6,859 | 290,033 (0%) | 0% | 3.8 | 25,893 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 41,171 | 301,295 (0%) | 0% | 0 | Common Stock | |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.19 per share. | 01 Mar 2024 | 4,403 | 296,892 (0%) | 0% | 7.2 | 31,669 | Common Stock |
| Orasure Technologies Inc. | Kathleen Weber Gallagher | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 23,866 | 271,887 (0%) | 0% | 0 | Common Stock | |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.39 per share. | 01 Feb 2024 | 11,763 | 260,124 (0%) | 0% | 7.4 | 86,987 | Common Stock |
| Orasure Technologies Inc. | Kathleen Weber Gallagher | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.19 per share. | 05 Jan 2024 | 6,679 | 248,021 (0%) | 0% | 8.2 | 54,671 | Common Stock |
| Orasure Technologies Inc. | Weber Gallagher Kathleen | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 8.05 per share. | 19 Dec 2023 | 24,129 | 254,700 (0%) | 0% | 8.0 | 194,219 | Common Stock |
| Orasure Technologies Inc. | Gallagher Weber Kathleen | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 4,129 | 0 | - | - | Non-Qualified Stock Options | |
| Orasure Technologies Inc. | Gallagher Weber Kathleen | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.71 per share. | 19 Dec 2023 | 4,129 | 278,829 (0%) | 0% | 5.7 | 23,597 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 46,371 | 274,700 (0%) | 0% | 0 | Common Stock | |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 5.44 per share. | 01 Feb 2023 | 39,016 | 238,218 (0%) | 0% | 5.4 | 212,442 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 5.45 per share. | 01 Feb 2023 | 13,006 | 240,109 (0%) | 0% | 5.4 | 70,818 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.44 per share. | 01 Feb 2023 | 11,115 | 227,103 (0%) | 0% | 5.4 | 60,521 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.45 per share. | 01 Feb 2023 | 3,705 | 236,404 (0%) | 0% | 5.4 | 20,174 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.44 per share. | 01 Feb 2023 | 3,234 | 228,329 (0%) | 0% | 5.4 | 17,609 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.45 per share. | 01 Feb 2023 | 3,112 | 233,292 (0%) | 0% | 5.4 | 16,945 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.44 per share. | 01 Feb 2023 | 1,729 | 231,563 (0%) | 0% | 5.4 | 9,414 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 05 Jan 2023 | 6,857 | 199,202 (0%) | 0% | 4.9 | 33,428 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | President - Molecular Sol | Grant, award, or other acquisition of securities at price $ 8.86 per share. | 01 Feb 2022 | 34,061 | 201,852 (0%) | 0% | 8.9 | 301,780 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | President - Molecular Sol | Grant, award, or other acquisition of securities at price $ 8.86 per share. | 01 Feb 2022 | 6,989 | 208,841 (0%) | 0% | 8.9 | 61,923 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | President - Molecular Sol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 3,592 | 169,476 (0%) | 0% | 8.9 | 31,825 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | President - Molecular Sol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 2,782 | 206,059 (0%) | 0% | 8.9 | 24,649 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | President - Molecular Sol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 1,685 | 167,791 (0%) | 0% | 8.9 | 14,929 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | President - Molecular Sol | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 1,467 | 173,068 (0%) | 0% | 8.9 | 12,998 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | President - Molecular Sol | Grant, award, or other acquisition of securities at price $ 8.21 per share. | 05 Jan 2022 | 60,901 | 174,535 (0%) | 0% | 8.2 | 499,997 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | EVP BU Lead - Molecular | Grant, award, or other acquisition of securities at price $ 15.55 per share. | 01 Feb 2021 | 18,218 | 109,338 (0%) | 0% | 15.6 | 283,379 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | EVP BU Lead - Molecular | Grant, award, or other acquisition of securities at price $ 15.55 per share. | 01 Feb 2021 | 6,006 | 115,344 (0%) | 0% | 15.6 | 93,423 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 3,057 | 91,120 (0%) | 0% | 15.6 | 47,551 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 1,710 | 113,634 (0%) | 0% | 15.6 | 26,599 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 1,466 | 94,177 (0%) | 0% | 15.6 | 22,803 | Common Stock |
| Orasure Technologies Inc. | Kathleen Gallagher Weber | EVP BU Lead - Molecular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.55 per share. | 01 Feb 2021 | 901 | 95,643 (0%) | 0% | 15.6 | 14,015 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges